Malignant Hyperthermia Registry and Genetic Testing
NCT02964481 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2020-09-03
Summary
The purpose of this study is to to determine the penetrance of known and probable pathogenic variants in genes and the factors that contribute to penetrance in a population of children and adults in the United States exposed to Malignant Hyperthermia (MH) trigger agents.
Conditions
- Malignant Hyperthermia
Interventions
- GENETIC
-
Whole exome sequencing
DNA sequencing of protein coding sections of all genes
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-18
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
NCT00436696 ·Status: COMPLETED
-
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
NCT06543511 ·Status: WITHDRAWN ·Phase: NA
-
Gene Mutation Spectrum of Malignant Hyperthermia in China
NCT04474860 ·Status: UNKNOWN
-
Identification of Genomic Changes in Families Having Multiple Members With Tumors
NCT02386241 ·Status: TERMINATED
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
NCT04456140 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
NCT00131014 ·Status: RECRUITING
-
Molecular Epidemiology of Pediatric Germ Cell Tumors
NCT05564026 ·Status: RECRUITING
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
NCT06060561 ·Status: SUSPENDED
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
Thiopurine Methyltransferase Polymorphisms Evaluation
NCT00166647 ·Status: WITHDRAWN
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
NCT01528956 ·Status: COMPLETED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT02253251 ·Status: RECRUITING
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED